SKI Market

Indian Indices

Nifty

25,574.35 82.05
(0.32%)

Sensex

83,535.35 319.07
( 0.38%)

Bank Nifty

57,937.55 60.75
( 0.10%)

Nifty IT

35,688.25 570.65
( 1.62%)

Global Indices

Nasdaq

16.76 83.45
(0.18%)

Dow Jones

6,751.11 9.79
(0.15%)

Hang Seng

50,901.74 625.37
(1.24%)

Nikkei 225

9,688.02 -47.76
(-0.49%)

Forex

USD-INR

88.62 -0.02
(-0.03%)

EUR-INR

102.12 0.31
(0.30%)

GBP-INR

116.02 0.48
(0.42%)

JPY-INR

0.58 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

140.8744507

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

17885.41

EPS(TTM)

Face Value()

Div & Yield %

0.44

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	745.70	784.70	810.10	725.73	2709.50	3139.90
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	745.70	784.70	810.10	725.73	2709.50	3139.90
Other Income	99.60	103.40	137.90	126.16	47.88	173.23
Stock Adjustments	6.70	-39.00	-3.50	40.61	-55.21	108.32
Total Income	852.00	849.10	944.50	892.50	2702.17	3421.45
EXPENDITURE :
Raw Materials	282.50	316.50	411.10	372.89	1395.15	1792.74
Power & Fuel Cost	78.00	68.40	75.40	62.31	280.40	369.20
Employee Cost	203.00	190.00	167.30	163.64	220.67	264.90
Other Manufacturing Expenses	60.60	59.60	49.00	39.80	216.91	269.07
Selling & Administrative Expenses	91.10	88.60	93.00	111.59	100.02	143.14
Miscellaneous Expenses	16.30	6.10	7.70	9.65	14.07	39.96
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	731.50	729.20	803.50	759.88	2227.23	2879.02
Operating Profit	120.50	119.90	141.00	132.62	474.94	542.44
Interest	29.80	29.90	18.50	10.99	101.80	136.20
Gross Profit	90.70	90.00	122.50	121.63	373.14	406.24
Depreciation	53.10	48.30	43.20	36.91	99.97	107.40
Profit Before Tax	37.60	41.70	79.30	84.72	273.17	298.84
Tax	19.80	6.80	13.80	14.28	45.44	26.13
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.40	3.30	15.60	-10.05	13.25	-48.43
Reported Net Profit	19.20	31.60	49.90	80.49	214.48	321.14
Extraordinary Items	-5.30	-0.76	0.25	0.02	-0.19	-4.92
Adjusted Net Profit	24.50	32.36	49.65	80.47	214.67	326.06
Adjustment below Net Profit	3.30	0.00	-0.70	0.81	-212.82	-3.49
P & L Balance brought forward	1075.60	1123.60	1154.00	1152.37	1153.26	986.93
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	79.60	79.60	79.60	79.64	0.00	151.32
P & L Balance carried down	1018.50	1075.60	1123.60	1154.03	1154.92	1153.26
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	500.00	500.00	500.00	500.00	500.00	500.00
Dividend Per Share(Rs)	5.00	5.00	5.00	5.00	5.00	5.00
Earnings Per Share-Unit Curr	1.21	1.99	3.14	5.05	13.46	20.16
Earnings Per Share(Adj)-Unit Curr	1.21	1.99	3.14	5.05	13.46	17.49
Book Value-Unit Curr	145.79	149.34	151.86	153.11	80.51	163.67
Book Value(Adj)-Unit Curr	145.79	149.34	151.86	153.11	80.51	142.03

25,574.35 82.05 (0.32%)

83,535.35 319.07 ( 0.38%)

57,937.55 60.75 ( 0.10%)

35,688.25 570.65 ( 1.62%)

16.76 83.45 (0.18%)

6,751.11 9.79 (0.15%)

50,901.74 625.37 (1.24%)

9,688.02 -47.76 (-0.49%)

88.62 -0.02 (-0.03%)

102.12 0.31 (0.30%)

116.02 0.48 (0.42%)

0.58 0.00 (0.14%)